Evidence map›Paper›PMID 33190154›Full record

ArticleTransactions of the Royal Society of Tropical Medicine and Hygiene2020

A cross-sectional study to evaluate depression and quality of life among patients with lymphoedema due to podoconiosis, lymphatic filariasis and leprosy.

Oumer Ali, Kebede Deribe, Maya Semrau, Asrat Mengiste, Mersha Kinfe, Abraham Tesfaye, Stephen Bremner, Gail Davey, Abebaw Fekadu

Open access · bronzeAbstract read
In one paragraph

Article in Transactions of the Royal Society of Tropical Medicine and Hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Oumer AliCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT)-Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, 9086, Ethiopia.
Kebede DeribeCentre for Global Health Research, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9PX, UK.
Maya SemrauCentre for Global Health Research, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9PX, UK.
Asrat MengisteCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT)-Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, 9086, Ethiopia.
Mersha KinfeCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT)-Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, 9086, Ethiopia.
Abraham TesfayeCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT)-Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, 9086, Ethiopia.
Stephen BremnerCentre for Global Health Research, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9PX, UK.
Gail DaveyCentre for Global Health Research, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9PX, UK.
Abebaw FekaduCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT)-Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, 9086, Ethiopia.
Brighton and Sussex Medical School · GBAddis Ababa University · ET

Funding

Medical Research Council MR/M025470/1Wellcome Trust 201900/Z/16/Z
6 · The paper itself

Abstract

backgroundPodoconiosis, lymphatic filariasis (LF) and leprosy are neglected tropical diseases (NTDs) that cause lymphoedema. When left untreated, they lead to substantial disability. This study determined the quality of life (QOL) and depression associated with lymphoedema in patients with podoconiosis, LF and leprosy. The study was conducted in northwestern Ethiopia.

methodsThis baseline cross-sectional study, nested within an interventional, non-comparative, longitudinal study, included patients with lymphoedema. Depression and QOL were assessed using versions of the 9-item Patient Health Questionnaire and Dermatologic Life Quality Index (DLQI), respectively, that had been translated into Amharic and validated. Factors associated with depression and QOL were assessed using multivariate linear regression analysis.

resultsOf the 251 patients with lymphoedema included in the study, 119 (47.4%) had moderate to severe depression and overall QOL was poor (mean±standard deviation [SD] DLQI score: 11.4±4.2). Disability was significantly associated with depression (β=0.26 [95% confidence interval {CI} 0.19 to 0.33]). Currently receiving treatment (β=-3.05 [95% CI -5.25 to -0.85), disability (β=-0.08 [95% CI -0.15 to -0.01]) and social support (moderate support: β=-2.27 [95% CI -3.66 to -0.89] and strong support: β=-2.87 [95% CI -5.35 to -0.38]) were significantly associated with better QOL.

conclusionHigh levels of depression and low QOL were found among patients with lymphoedema due the three NTDs in Ethiopia.

Indexed as

ElephantiasisElephantiasis, FilarialLeprosyLymphedemaCross-Sectional StudiesDepressionEthiopiaHumansLongitudinal StudiesQuality of Lifedepressionleprosylymphatic filariasis (LF)lymphoedemapodoconiosisquality of life

Identifiers

PMID33190154
PMCPMC7738660
OpenAlexW3101918197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.